These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 22143079)

  • 1. Reverse remodeling in heart failure--mechanisms and therapeutic opportunities.
    Koitabashi N; Kass DA
    Nat Rev Cardiol; 2011 Dec; 9(3):147-57. PubMed ID: 22143079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.
    Cohn JN; Ferrari R; Sharpe N
    J Am Coll Cardiol; 2000 Mar; 35(3):569-82. PubMed ID: 10716457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial recovery and the failing heart: medical, device and mechanical methods.
    Goldfinger JZ; Nair AP
    Ann Glob Health; 2014; 80(1):55-60. PubMed ID: 24751565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalities.
    Gajarsa JJ; Kloner RA
    Heart Fail Rev; 2011 Jan; 16(1):13-21. PubMed ID: 20623185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing the remodeling process in heart failure: basic mechanisms and laboratory results.
    Francis GS
    Curr Opin Cardiol; 1998 May; 13(3):156-61. PubMed ID: 9649937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to attenuate pathological remodeling in heart failure.
    Eapen Z; Rogers JG
    Curr Opin Cardiol; 2009 May; 24(3):223-9. PubMed ID: 19318933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial reverse remodeling: how far can we rewind?
    Rodrigues PG; Leite-Moreira AF; Falcão-Pires I
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1402-22. PubMed ID: 26993225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversing chronic remodeling in heart failure.
    Mudd JO; Kass DA
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):585-98. PubMed ID: 17489680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
    Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure.
    St John Sutton M; Ghio S; Plappert T; Tavazzi L; Scelsi L; Daubert C; Abraham WT; Gold MR; Hassager C; Herre JM; Linde C;
    Circulation; 2009 Nov; 120(19):1858-65. PubMed ID: 19858419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial recovery and the failing heart: myth, magic, or molecular target?
    Mann DL; Barger PM; Burkhoff D
    J Am Coll Cardiol; 2012 Dec; 60(24):2465-72. PubMed ID: 23158527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of ventricular remodeling in heart failure clinical trials.
    Kirkpatrick JN; St John Sutton M
    Curr Heart Fail Rep; 2012 Dec; 9(4):328-36. PubMed ID: 22983907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological modulation of cardiovascular remodeling: a guide to heart failure therapy.
    Remme WJ
    Cardiovasc Drugs Ther; 2003 Jul; 17(4):349-60. PubMed ID: 14618097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs for left ventricular remodeling in heart failure.
    Frigerio M; Roubina E
    Am J Cardiol; 2005 Dec; 96(12A):10L-18L. PubMed ID: 16399088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).
    St John Sutton M; Cerkvenik J; Borlaug BA; Daubert C; Gold MR; Ghio S; Chirinos JA; Linde C; Ky B
    J Am Heart Assoc; 2015 Sep; 4(9):e002054. PubMed ID: 26363005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ACE-inhibitors and beta-blockers on left ventricular remodeling in chronic heart failure.
    Khattar RS
    Minerva Cardioangiol; 2003 Apr; 51(2):143-54. PubMed ID: 12783070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular reverse remodelling, long-term clinical outcome, and mode of death after cardiac resynchronization therapy.
    Foley PW; Chalil S; Khadjooi K; Irwin N; Smith RE; Leyva F
    Eur J Heart Fail; 2011 Jan; 13(1):43-51. PubMed ID: 21051462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study.
    Gold MR; Daubert C; Abraham WT; Ghio S; St John Sutton M; Hudnall JH; Cerkvenik J; Linde C
    Heart Rhythm; 2015 Mar; 12(3):524-530. PubMed ID: 25460860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic rationale for the use of beta-blockers in the treatment of heart failure.
    Sabbah HN
    Heart Fail Rev; 2004 Apr; 9(2):91-7. PubMed ID: 15516856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.